Whether for Medicinal, wellness or recreational purposes, on-going changes and challenges necessitate market leaders to act upon setting a strong foothold for a strong positioning within the global Cannabis markets.
IsCann is committed and focused on propelling the way for its alliances, partners and customers to unique branding capabilities through strong global scientific platforms.
As medical Cannabis is expected to grow from $2.9B today to $7.6B by 2020 and as the European continent is expected to become the world's largest medicinal cannabis market surpassing 50 Billion Euros by 2023, IsCann holds the necessary capabilities, strategic alliances and agreements with leading systems which provide an extensive distribution and marketing network platforms accross Europe, including the UK.
Through strong distribution and alliance networks, IsCann holds the potential of acting upon the opportunity to capitalize on the entire European Cannabis healthcare market.
Innovations to Markets